Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy
NCT ID: NCT02261194
Last Updated: 2016-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2014-10-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Self-Care Tools
The tool binder includes 3 core tools and 4 supplemental tools. The tools that will be provided include a variety of self-care approaches to manage depression including audio-visual, internet, and paper-based tools that might appeal to individuals with different learning styles. The 3 core tools consist of the Antidepressant Skills Workbook, a Mood Monitoring Tool, and a DVD on depression.
Self-Care Tools
Delayed Self-Care Tools
This group will receive the self-care tools at the conclusion of the study.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-Care Tools
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 50 years and older
* at least mild depressive symptoms (a score of 5 or more on the PHQ-9)
* no legal blindness (visual acuity better than 20/200 in better eye).
Exclusion Criteria
* suicidal intent
* ocular surgery during the study period (intravitreal anti-VEGF injections will be allowed, e.g. Lucentis)
* cognitive impairment
* inability to speak and understand French or English
* profound hearing impairment.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fonds de la Recherche en Santé du Québec
OTHER_GOV
Fondation Antoine Turmel
UNKNOWN
Maisonneuve-Rosemont Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ellen Freeman
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen E. Freeman, PhD
Role: PRINCIPAL_INVESTIGATOR
Maisonneuve-Rosemont Hospital and University of Montreal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Réseau Vision Freeman
Identifier Type: -
Identifier Source: org_study_id